Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
8.46
-0.27 (-3.09%)
At close: Mar 28, 2025, 4:00 PM
8.52
+0.06 (0.69%)
After-hours: Mar 28, 2025, 7:50 PM EDT

Avalo Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Revenue
0.441.9218.055.46.7
Upgrade
Revenue Growth (YoY)
-77.08%-89.34%234.40%-19.42%-0.76%
Upgrade
Cost of Revenue
15.289.9525.9950.1225.24
Upgrade
Gross Profit
-14.84-8.02-7.94-44.72-18.54
Upgrade
Selling, General & Admin
17.2410.313.9124.6619.76
Upgrade
Research & Development
8.85.128.0511.217.26
Upgrade
Operating Expenses
26.0415.422237.4128.76
Upgrade
Operating Income
-40.87-23.44-29.94-82.13-47.29
Upgrade
Interest Expense
--3.42-4.17-2.39-
Upgrade
Interest & Investment Income
3.32---0.05
Upgrade
Other Non Operating Income (Expenses)
30.18-0.76-0.02-0.020.41
Upgrade
EBT Excluding Unusual Items
-7.37-27.62-34.13-84.55-46.84
Upgrade
Merger & Restructuring Charges
---7.5--
Upgrade
Impairment of Goodwill
--3.91---
Upgrade
Gain (Loss) on Sale of Investments
----5.21
Upgrade
Pretax Income
-35.02-31.53-41.63-84.55-67.18
Upgrade
Income Tax Expense
0.110.010.03-0.2-2.79
Upgrade
Earnings From Continuing Operations
-35.13-31.54-41.66-84.35-64.38
Upgrade
Earnings From Discontinued Operations
----0.030.88
Upgrade
Net Income
-35.13-31.54-41.66-84.38-63.5
Upgrade
Net Income to Common
-35.13-31.54-41.66-84.38-63.5
Upgrade
Shares Outstanding (Basic)
40000
Upgrade
Shares Outstanding (Diluted)
70000
Upgrade
Shares Change (YoY)
2599.19%608.45%8.32%41.86%28.52%
Upgrade
EPS (Basic)
-7.94-113.58-1062.65-2331.41-2489.12
Upgrade
EPS (Diluted)
-20.91-113.58-1062.65-2331.41-2489.12
Upgrade
Free Cash Flow
-49.06-30.84-26.85-71.01-40.6
Upgrade
Free Cash Flow Per Share
-6.54-111.04-684.81-1961.95-1591.55
Upgrade
Gross Margin
---43.98%--276.70%
Upgrade
Operating Margin
-9267.80%-1218.50%-165.86%-1521.56%-705.99%
Upgrade
Profit Margin
-7965.76%-1639.50%-230.78%-1563.10%-947.90%
Upgrade
Free Cash Flow Margin
-11123.81%-1602.81%-148.72%-1315.39%-606.09%
Upgrade
EBITDA
-40.7-23.29-29.77-80.48-45.45
Upgrade
EBITDA Margin
---164.94%--
Upgrade
D&A For EBITDA
0.170.160.171.661.84
Upgrade
EBIT
-40.87-23.44-29.94-82.13-47.29
Upgrade
EBIT Margin
---165.86%--
Upgrade
Revenue as Reported
0.441.9218.055.46.7
Upgrade
Updated Mar 20, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q